Your browser doesn't support javascript.
loading
Investigation of thrombin concentration at the time of clot formation in simultaneous thrombin and fibrin generation assays.
Tarandovskiy, Ivan D; Surov, Stepan S; Parunov, Leonid A; Liang, Yideng; Jankowski, Wojciech; Sauna, Zuben E; Ovanesov, Mikhail V.
Affiliation
  • Tarandovskiy ID; U.S. Food and Drug Administration, 10903 New Hampshire Avenue, Silver Spring, MD, 20993, USA.
  • Surov SS; U.S. Food and Drug Administration, 10903 New Hampshire Avenue, Silver Spring, MD, 20993, USA.
  • Parunov LA; U.S. Food and Drug Administration, 10903 New Hampshire Avenue, Silver Spring, MD, 20993, USA.
  • Liang Y; U.S. Food and Drug Administration, 10903 New Hampshire Avenue, Silver Spring, MD, 20993, USA.
  • Jankowski W; U.S. Food and Drug Administration, 10903 New Hampshire Avenue, Silver Spring, MD, 20993, USA.
  • Sauna ZE; U.S. Food and Drug Administration, 10903 New Hampshire Avenue, Silver Spring, MD, 20993, USA.
  • Ovanesov MV; U.S. Food and Drug Administration, 10903 New Hampshire Avenue, Silver Spring, MD, 20993, USA. ovanesov@gmail.com.
Sci Rep ; 14(1): 9225, 2024 04 22.
Article in En | MEDLINE | ID: mdl-38649717
ABSTRACT
Thrombin generation (TG) and fibrin clot formation represent the central process of blood coagulation. Up to 95% of thrombin is considered to be generated after the clot is formed. However, this was not investigated in depth. In this study, we conducted a quantitative analysis of the Thrombin at Clot Time (TCT) parameter in 5758 simultaneously recorded TG and clot formation assays using frozen plasma samples from commercial sources under various conditions of activation. These samples were supplemented with clotting factor concentrates, procoagulant lipid vesicles and a fluorogenic substrate and triggered with tissue factor (TF). We found that TCT is often close to a 10% of thrombin peak height (TPH) yet it can be larger or smaller depending on whether the sample has low or high TPH value. In general, the samples with high TPH are associated with elevated TCT. TCT appeared more sensitive to some procoagulant phenotypes than other commonly used parameters such as clotting time, TPH or Thrombin Production Rate (TPR). In a minority of cases, TCT were not predicted from TG parameters. For example, elevated TCT (above 15% of TPH) was associated with either very low or very high TPR values. We conclude that clotting and TG assays may provide complementary information about the plasma sample, and that the TCT parameter may serve as an additional marker for the procoagulant potential in plasma sample.
Subject(s)

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Blood Coagulation / Fibrin / Thrombin Limits: Humans Language: En Journal: Sci Rep Year: 2024 Document type: Article Affiliation country:

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Blood Coagulation / Fibrin / Thrombin Limits: Humans Language: En Journal: Sci Rep Year: 2024 Document type: Article Affiliation country: